Your browser doesn't support javascript.
loading
DNA methylation signatures of incident coronary heart disease: findings from epigenome-wide association studies.
Xia, Yujing; Brewer, Alison; Bell, Jordana T.
Afiliação
  • Xia Y; Department of Twin Research and Genetic Epidemiology, Kings College London, London, SE1 7EH, UK.
  • Brewer A; School of Cardiovascular Medicine and Sciences, James Black Centre, King's College London British Heart Foundation Centre of Excellence, 125 Coldharbour Lane, London, SE5 9NU, UK.
  • Bell JT; Department of Twin Research and Genetic Epidemiology, Kings College London, London, SE1 7EH, UK. jordana.bell@kcl.ac.uk.
Clin Epigenetics ; 13(1): 186, 2021 10 09.
Article em En | MEDLINE | ID: mdl-34627379
Coronary heart disease (CHD) is a type of cardiovascular disease (CVD) that affects the coronary arteries, which provide oxygenated blood to the heart. It is a major cause of mortality worldwide. Various prediction methods have been developed to assess the likelihood of developing CHD, including those based on clinical features and genetic variation. Recent epigenome-wide studies have identified DNA methylation signatures associated with the development of CHD, indicating that DNA methylation may play a role in predicting future CHD. This narrative review summarises recent findings from DNA methylation studies of incident CHD (iCHD) events from epigenome-wide association studies (EWASs). The results suggest that DNA methylation signatures may identify new mechanisms involved in CHD progression and could prove a useful adjunct for the prediction of future CHD.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Metilação de DNA / Doença das Coronárias / Estudo de Associação Genômica Ampla Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Metilação de DNA / Doença das Coronárias / Estudo de Associação Genômica Ampla Idioma: En Ano de publicação: 2021 Tipo de documento: Article